Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer

Significant number of prostate tumors are slow growing and could probably be left untreated. However, many are aggressive and can spread rapidly causing patient suffering and/or death. Current technology does not allow physicians to differentiate between slow growing and aggressive tumors at diagnos...

Full description

Bibliographic Details
Main Authors: Amit M. Algotar PhD, MBBS, Steven P. Stratton PhD, James Ranger-Moore PhD, M. Suzanne Stratton PhD, C.H. Hsu PhD, Frederick R. Ahmann MD, Raymond B. Nagle MD, PhD, Patricia A. Thompson PhD
Format: Article
Language:English
Published: SAGE Publishing 2011-05-01
Series:American Journal of Men's Health
Online Access:https://doi.org/10.1177/1557988310390030
_version_ 1828400923578204160
author Amit M. Algotar PhD, MBBS
Steven P. Stratton PhD
James Ranger-Moore PhD
M. Suzanne Stratton PhD
C.H. Hsu PhD
Frederick R. Ahmann MD
Raymond B. Nagle MD, PhD
Patricia A. Thompson PhD
author_facet Amit M. Algotar PhD, MBBS
Steven P. Stratton PhD
James Ranger-Moore PhD
M. Suzanne Stratton PhD
C.H. Hsu PhD
Frederick R. Ahmann MD
Raymond B. Nagle MD, PhD
Patricia A. Thompson PhD
author_sort Amit M. Algotar PhD, MBBS
collection DOAJ
description Significant number of prostate tumors are slow growing and could probably be left untreated. However, many are aggressive and can spread rapidly causing patient suffering and/or death. Current technology does not allow physicians to differentiate between slow growing and aggressive tumors at diagnosis. Hence, many patients are exposed to invasive treatment and its associated morbidities such as incontinence and impotence. Markers that enable differentiation between slow and fast progressing cancer will allow physicians to prevent unnecessary treatments on men who may not need them, and focus on the men with aggressive disease. A longitudinal study was conducted ( N = 140) using mixed effects regression models to determine the association of obesity and smoking toward prostate cancer progression. These models account for correlation because of repeated measures over time, thus, using maximum amount of information provided by the subject. Estimates thus obtained are more robust and reliable than those obtained using data from a single time point. Rate of change of prostate-specific antigen (PSA) over time (PSA velocity) was used as a measure of prostate cancer progression. Results indicate that PSA velocity of overweight and obese subjects (0.59 and 1.05 ng/mL/year) was not significantly different as compared with normal weight subjects ( p values .91 and .31, respectively). For men in the highest tertile of pack-years of smoking, PSA velocity was significantly higher as compared with never smokers 1.57 ng/mL/year ( p = .04). Further studies with larger sample sizes and study designs specific to above exposures are needed before recommendations can be made to reduce weight or reduce/quit smoking.
first_indexed 2024-12-10T09:38:58Z
format Article
id doaj.art-8e665e97e1204deba9a8d9fd8d6fee53
institution Directory Open Access Journal
issn 1557-9883
language English
last_indexed 2024-12-10T09:38:58Z
publishDate 2011-05-01
publisher SAGE Publishing
record_format Article
series American Journal of Men's Health
spelling doaj.art-8e665e97e1204deba9a8d9fd8d6fee532022-12-22T01:54:04ZengSAGE PublishingAmerican Journal of Men's Health1557-98832011-05-01510.1177/1557988310390030Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate CancerAmit M. Algotar PhD, MBBSSteven P. Stratton PhDJames Ranger-Moore PhDM. Suzanne Stratton PhDC.H. Hsu PhDFrederick R. Ahmann MDRaymond B. Nagle MD, PhDPatricia A. Thompson PhDSignificant number of prostate tumors are slow growing and could probably be left untreated. However, many are aggressive and can spread rapidly causing patient suffering and/or death. Current technology does not allow physicians to differentiate between slow growing and aggressive tumors at diagnosis. Hence, many patients are exposed to invasive treatment and its associated morbidities such as incontinence and impotence. Markers that enable differentiation between slow and fast progressing cancer will allow physicians to prevent unnecessary treatments on men who may not need them, and focus on the men with aggressive disease. A longitudinal study was conducted ( N = 140) using mixed effects regression models to determine the association of obesity and smoking toward prostate cancer progression. These models account for correlation because of repeated measures over time, thus, using maximum amount of information provided by the subject. Estimates thus obtained are more robust and reliable than those obtained using data from a single time point. Rate of change of prostate-specific antigen (PSA) over time (PSA velocity) was used as a measure of prostate cancer progression. Results indicate that PSA velocity of overweight and obese subjects (0.59 and 1.05 ng/mL/year) was not significantly different as compared with normal weight subjects ( p values .91 and .31, respectively). For men in the highest tertile of pack-years of smoking, PSA velocity was significantly higher as compared with never smokers 1.57 ng/mL/year ( p = .04). Further studies with larger sample sizes and study designs specific to above exposures are needed before recommendations can be made to reduce weight or reduce/quit smoking.https://doi.org/10.1177/1557988310390030
spellingShingle Amit M. Algotar PhD, MBBS
Steven P. Stratton PhD
James Ranger-Moore PhD
M. Suzanne Stratton PhD
C.H. Hsu PhD
Frederick R. Ahmann MD
Raymond B. Nagle MD, PhD
Patricia A. Thompson PhD
Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
American Journal of Men's Health
title Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
title_full Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
title_fullStr Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
title_full_unstemmed Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
title_short Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
title_sort association of obesity and smoking with psa and psa velocity in men with prostate cancer
url https://doi.org/10.1177/1557988310390030
work_keys_str_mv AT amitmalgotarphdmbbs associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer
AT stevenpstrattonphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer
AT jamesrangermoorephd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer
AT msuzannestrattonphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer
AT chhsuphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer
AT frederickrahmannmd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer
AT raymondbnaglemdphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer
AT patriciaathompsonphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer